Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Clinical Therapeutics|November 18, 2005
Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension studyPeter D Donofrio, Philip Raskin, Norman R Rosenthal, et al.
Diabetes Care|June 29, 2005
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trialJay S Skyler, Ruth S Weinstock, Philip Raskin, et al.
Diabetes Care|May 22, 2008
Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathyWilliam W Chance, Chanhaeng Rhee, Cuneyt Yilmaz, et al.
Journal of Diabetes and Its Complications|November 11, 2010
The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetesSusan L Johnson, Laura N McEwen, Christopher A Newton, et al.
Journal of Diabetes and Its Complications|October 20, 2012
Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markersMay-Yun Wang, Xinxin Yu, Young Lee, et al.
Diabetes Care|March 18, 2009
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)Bernard Zinman, John Gerich, John B Buse, et al.
American Journal of Preventive Cardiology|August 31, 2023
Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohortSangeeta R Kashyap, Cyrus Desouza, Vanita R Aroda, et al.
Diabetes Care|March 5, 2002
Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetesBruce Bode, Richard Weinstein, David Bell, et al.
Diabetes, Obesity & Metabolism|December 15, 2020
Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort studyEdward B Jude, Carlos Trescoli, Rifat Emral, et al.
JACC. Cardiovascular Imaging|March 18, 2019
The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC TrialsMatthew Budoff, Jye-Yu C Backlund, David A Bluemke, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Clinical Therapeutics|November 18, 2005
Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension studyPeter D Donofrio, Philip Raskin, Norman R Rosenthal, et al.
Diabetes Care|June 29, 2005
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trialJay S Skyler, Ruth S Weinstock, Philip Raskin, et al.
Diabetes Care|May 22, 2008
Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathyWilliam W Chance, Chanhaeng Rhee, Cuneyt Yilmaz, et al.
Journal of Diabetes and Its Complications|November 11, 2010
The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetesSusan L Johnson, Laura N McEwen, Christopher A Newton, et al.
Journal of Diabetes and Its Complications|October 20, 2012
Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markersMay-Yun Wang, Xinxin Yu, Young Lee, et al.
Diabetes Care|March 18, 2009
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)Bernard Zinman, John Gerich, John B Buse, et al.
American Journal of Preventive Cardiology|August 31, 2023
Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohortSangeeta R Kashyap, Cyrus Desouza, Vanita R Aroda, et al.
Diabetes Care|March 5, 2002
Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetesBruce Bode, Richard Weinstein, David Bell, et al.
Diabetes, Obesity & Metabolism|December 15, 2020
Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort studyEdward B Jude, Carlos Trescoli, Rifat Emral, et al.
JACC. Cardiovascular Imaging|March 18, 2019
The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC TrialsMatthew Budoff, Jye-Yu C Backlund, David A Bluemke, et al.
Pageof 13